ASCIA develops a range of reports and submissions relevant to allergy and other immune diseases.
These include ASCIA Annual Highlights, ASCIA Scope of Practice documents, ASCIA AGM Minutes and Annual Reports, National Allergy Strategy, ASCIA/NPS Choosing Wisely Australia and RACP Evolve recommendations, Allergy in Australia 2014, Allergy and Immune Diseases in Australia (AIDA) Report 2013, ASCIA Education Resources Report 2013, Economic Impact of Allergies Report 2007
Summaries of highlights and achievements from 2018, 2017, 2016, 2015 and 2014 are available at: www.allergy.org.au/about-ascia/highlights
Current ASCIA initiatives are available at www.allergy.org.au/about-ascia/ascia-initiatives
Scope of Practice - Allergy Skin Testing Testing in Australia 2018
ASCIA has been requested to develop this Scope of Practice document in response to the Medicare Benefits Schedule (MBS) item number changes implemented by the MBS Review Taskforce, effective 1 November 2018. Whilst these changes were not initiated by ASCIA, the previously proposed item numbers were significantly modified in response to a submission made by ASCIA in July 2017, to ensure patients with complex allergic disease are not disadvantaged.
Scope of Practice - Specialist Physicians in Immunology and Allergy in Australia 2014
The aim of this Scope of Practice is to outline the range of practice of specialist physicians in Immunology and Allergy in Australia and ensure that patients with allergic and other immune diseases receive the highest standard of care, in line with best clinical practice.
ASCIA Annual General Meeting Minutes are available at www.allergy.org.au/members/ascia-agm
ASCIA Annual Reports are available at www.allergy.org.au/members/ascia-annual-reports
ASCIA and Allergy & Anaphylaxis Australia (A&AA), as the leading medical and patient organisations for allergy in Australia developed the first National Allergy Strategy for Australia, in collaboration with other stakeholder organisations, which was launched in August 2015. To access the National Allergy Strategy go to www.nationalallergystrategy.org.au
In 2017 and 2018 the following National Allergy Strategy projects were completed and can be accessed online free of charge:
250K - a hub for young people with severe allergy www.250K.org.au
All About Allergens - food service e-training www.foodallergytraining.org.au
Nip Allergies in the Bub - pilot launch in WA www.preventallergies.org.au
ASCIA was the 1st Specialty Society affiliated with the Royal Australasian College of Physicians (RACP) to be involved in Choosing Wisely Australia, a health profession led initiative faciliated by National Prescribing Service (PBS) MedicineWise and the RACP Evolve program. The ASCIA list of 5 things that clinicians and consumers should question is available at:
For further information about Choosing Wisely Australia go to www.choosingwisely.org.au
For further information about the RACP Evolve program go to https://evolve.edu.au/about
Prior to ASCIA developing a National Allergy Strategy for Australia, in conjunction with the national patient support organisation, Allergy & Anaphylaxis Australia (A&AA), the following report was developed in 2014.
The following report on allergy and other immune diseases (immunodeficiency and autoimmune diseases) was developed in 2013.
ASCIA has been developing web based education resources since 1999. In 2013, the following report was developed to outline the large range of web based educational resources that are all available at no charge on the ASCIA website.
The cost of allergies to the Australian economy is estimated to be $7.8 billion, with lost productivity and health system expenditure the major contributing factors. Furthermore, most Australians with allergies face a wait many months to see a specialist, if they can access care at all. These are among key findings in the following report 'Economic Impact of Allergies' by Access Economics that was released by ASCIA in November 2007.
Content updated November 2019